EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epidemiology of Compensated Advanced Chronic Liver Disease (cACLD) in the United States: Insights From the National Health and Nutrition Examination Survey, 2017-2020

Ritik M Goyal, Apoorva Doshi, Sameer Rao, Komal Arora, Supriya Maheshwari, Paul Gaglio

Clinical Gastroenterology and Hepatology · 2026-03 · 24 (3) · 754-762.e3

DOI: 10.1016/j.cgh.2025.06.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-03. Verfasst von Ritik M Goyal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Rutgers New Jersey Medical School, Newark, New Jersey. Electronic address: rg1229@njms.rutgers.edu. Hauptthemen laut MEDLINE: Liver Cirrhosis, Liver Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Compensated advanced chronic liver disease (cACLD) encompasses advanced fibrosis and cirrhosis in asymptomatic patients at risk of developing clinically significant portal hypertension. Patients having cACLD are at high risk of decompensation and liver-related mortality and hence require further evaluation. Due to limited epidemiologic data on cACLD, we aimed to assess its prevalence in the United States (U.S.). METHODS: We performed a cross-sectional study analyzing adults who underwent transient elastography using the National Health and Nutrition Examination Survey (NHANES) database from 2017 to March 2020. The Baveno VII's liver stiffness measurement criteria were applied:

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisLiver DiseasesHumansMaleFemaleUnited StatesMiddle AgedNutrition SurveysCross-Sectional StudiesAdultElasticity Imaging TechniquesPrevalenceAgedRisk FactorsYoung Adult

Stichwörter der Autor:innen

Clinically Significant Portal Hypertension (CSPH)Compensated Advanced Chronic Liver Disease (cACLD)Liver FibrosisTransient Elastography

Autor:innen und Institutionen

  • Department of Internal Medicine, Rutgers New Jersey Medical School, Newark, New Jersey. Electronic address: rg1229@njms.rutgers.edu.
  • Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama.
  • Department of Internal Medicine, Rutgers New Jersey Medical School, Newark, New Jersey.
  • Department of Internal Medicine, New York Medical College/St. Mary's Hospital, Passaic, New Jersey.
  • Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

Zitieren

APA

Goyal, R. M., Doshi, A., Rao, S., Arora, K., Maheshwari, S., & Gaglio, P. (2026). Epidemiology of Compensated Advanced Chronic Liver Disease (cACLD) in the United States: Insights From the National Health and Nutrition Examination Survey, 2017-2020. Clinical Gastroenterology and Hepatology, 24(3), 754-762.e3. https://doi.org/10.1016/j.cgh.2025.06.010

Vancouver

Goyal RM, Doshi A, Rao S, Arora K, Maheshwari S, Gaglio P. Epidemiology of Compensated Advanced Chronic Liver Disease (cACLD) in the United States: Insights From the National Health and Nutrition Examination Survey, 2017-2020. Clinical Gastroenterology and Hepatology. 2026;24(3):754-762.e3. doi:10.1016/j.cgh.2025.06.010

BibTeX
@article{Goyal2026,
  author = {Goyal, Ritik M and Doshi, Apoorva and Rao, Sameer and Arora, Komal and Maheshwari, Supriya and Gaglio, Paul},
  title = {Epidemiology of Compensated Advanced Chronic Liver Disease (cACLD) in the United States: Insights From the National Health and Nutrition Examination Survey, 2017-2020},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {3},
  pages = {754--762.e3},
  doi = {10.1016/j.cgh.2025.06.010}
}
Kostenlos starten →